Updated January 22 at 6:26pm
Biotechnology
76 results total, viewing 61 - 70
Nominations and applications for the newly expanded 2016 Tech10 Awards program are being accepted until Aug. 15. more
Alexion Pharmaceuticals Inc. is planning a $200 million phased expansion of its manufacturing plant here, to facilitate production of its drug, Soliris, and other products. more
Flaws with a heart device that Medtronic PLC bought last month as part of a $1 billion deal have been deemed potentially life-threatening by U.S. regulators. more
After sitting out for most of the biotech acquisition frenzy of 2015, Amgen Inc. is ready to do a deal. more
What are the biggest hurdles to starting a business in Rhode Island? Time is money. One time delay can have a negative domino effect on your schedule, which ultimately affects your budget. Rhode Island's size can be an asset when starting a … more
To begin building a new economy, Rhode Island has made significant investments in growth and innovation. As a business owner, I understand that investing in the core parts of my business is what it takes to grow. On a far larger scale, the same … more
Southcoast Health recently announced that partial knee replacement surgeries are now being offered with the Navio Surgical System. more
Biotechnology drugmaker AbbVie Inc. filed a lawsuit seeking to block Amgen Inc. from selling a copy of the arthritis medicine Humira, its top seller. more
Biotech could really use the clean slate of a New Year. The Nasdaq Biotech Index collapsed 28 percent in the opening weeks of 2016 and never fully recovered, ending the year down about 22 percent. more
For all the fuss over tax inversions and the Obama administration’s efforts to prevent them, shares of companies that were able to plow their inversion deals through to the finish line and lock in all those (some would call them nefarious) benefits have to be soaring, right? Not so for Medtronic. more
« Prev | 1 2 | 3 | 4 | 5 | 6 | 7 | 8 Next »